Heron Therapeutics, Inc. (NASDAQ: HRTX)
$1.5700
-0.0300 ( -0.63% ) 322.0K
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Market Data
Open
$1.5700
Previous close
$1.6000
Volume
322.0K
Market cap
$243.35M
Day range
$1.5550 - $1.6250
52 week range
$1.0400 - $3.9300
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 60 | May 07, 2024 |
| 8-k | 8K-related | 12 | May 07, 2024 |
| def | Proxies and info statements | 5 | Apr 29, 2024 |
| ars | Annual reports | 1 | Apr 29, 2024 |
| 4 | Insider transactions | 2 | Apr 19, 2024 |
| 4 | Insider transactions | 2 | Apr 19, 2024 |
| 4 | Insider transactions | 1 | Apr 19, 2024 |
| pre | Proxies and info statements | 5 | Apr 19, 2024 |
| 4 | Insider transactions | 2 | Apr 05, 2024 |
| 8-k | 8K-related | 13 | Mar 21, 2024 |